HVIVO PLC — Investor Relations & Filings
hVIVO plc is a full-service contract research organization (CRO) and a leading specialist in human challenge trials. The company provides end-to-end clinical development solutions for a global biopharma client base, focusing on infectious and respiratory diseases. Its services span from preclinical consultancy to Phase III clinical trials, including first-in-human studies, biometry, and consulting. hVIVO operates a state-of-the-art quarantine facility in London and provides advanced laboratory services under its hLAB brand. Through subsidiaries such as CRS and Venn Life Sciences, it offers early-phase clinical trial expertise and patient recruitment across multiple clinical sites. The company's integrated approach is designed to accelerate the development of vaccines and therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Consultancy contract with Decoy Therapeutics | 2026-06-01 | English | |
| Grant of awards under Long Term Incentive Plan | 2026-05-29 | English | |
| Group of companies' accounts made up to 2025-12-31 | 2026-05-29 | English | |
| Capital Markets Day | 2026-05-20 | English | |
| Result of AGM | 2026-05-13 | English | |
| Holding(s) in Company | 2026-05-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47916895 | Consultancy contract with Decoy Therapeutics | 2026-06-01 | English | ||
| 47878575 | Grant of awards under Long Term Incentive Plan | 2026-05-29 | English | ||
| 47905660 | Group of companies' accounts made up to 2025-12-31 | 2026-05-29 | English | ||
| 46579419 | Capital Markets Day | 2026-05-20 | English | ||
| 45604509 | Result of AGM | 2026-05-13 | English | ||
| 45196271 | Holding(s) in Company | 2026-05-12 | English | ||
| 42452157 | £6m Influenza HCT contract signed | 2026-05-07 | English | ||
| 36206442 | Director/PDMR Shareholding | 2026-04-24 | English | ||
| 35137173 | HCT contract signed with ILiAD Biotechnologies | 2026-04-22 | English | ||
| 34661204 | Annual Report & Notice of AGM | 2026-04-17 | English | ||
| 34655198 | hVIVO launches unified brand identity | 2026-04-14 | English | ||
| 34655136 | Influenza HCT contract signed with Traws Pharma | 2026-04-14 | English | ||
| 33684812 | Notice of Results | 2026-04-07 | English | ||
| 33051244 | Holding(s) in Company | 2026-03-26 | English | ||
| 32851117 | Holding(s) in Company | 2026-02-27 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for HVIVO PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
HVIVO PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7697/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7697 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7697 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7697 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7697}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HVIVO PLC (id: 7697)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.